Amag investigates anemia drug after report of death in Switzerland

(Reuters) – Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag’s anemia drug, Rienso, because of a death and several cases of hypersensitivity. Amag shares were down about 5 percent at $23.75 in after-market trading on Tuesday. “The batch was only distributed to and sold in Switzerland and the recall is limited to the specific batch and specifically Switzerland,” Lexington, Massachusetts-based Amag said in a regulatory filing on Tuesday. (http://r.reuters. …